BioCryst Pharmaceuticals
BCRX
#4607
Rank
โ‚น141.45 B
Marketcap
โ‚น683.74
Share price
2.39%
Change (1 day)
7.77%
Change (1 year)

BioCryst Pharmaceuticals (BCRX) - Total debt

Total debt on the balance sheet as of June 2024 : โ‚น68.93 B

According to BioCryst Pharmaceuticals 's latest financial reports the company's total debt is โ‚น68.93 B. A companyโ€™s total debt is the sum of all current and non-current debts.

BioCryst Pharmaceuticals - Total debt on balance sheet (from 1996 to 2024)

Total debt by year

Year Total debt Change
2023-12-31โ‚น68.69 B11.96%
2022-12-31โ‚น61.35 B38.78%
2021-12-31โ‚น44.20 B116.64%
2020-12-31โ‚น20.40 B238.67%
2019-12-31โ‚น6.02 B40.12%
2018-12-31โ‚น4.30 B23.08%
2017-12-31โ‚น3.49 B-4.29%
2016-12-31โ‚น3.65 B82.06%
2015-12-31โ‚น2.00 B5.62%
2014-12-31โ‚น1.89 B2.4%
2013-12-31โ‚น1.85 B12.86%
2012-12-31โ‚น1.64 B3.52%
2011-12-31โ‚น1.58 B
2000-12-31โ‚น0.45 M
1997-12-31โ‚น3.92 M-63.56%
1996-12-31โ‚น10.78 M

Total debt for similar companies or competitors

Company Total debt differencediff. Country
โ‚น62.32 B-9.59%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น114.92 B 66.72%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น0.12 B-99.82%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น19.56 B-71.61%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.958 T 2,741.78%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น0.20 B-99.71%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.798 T 2,508.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚น72.33 B 4.93%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.01 B-98.52%๐Ÿ‡บ๐Ÿ‡ธ USA